MannKind | MNKD - Trade Creditors


MannKind reported $7.27M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
Adma Biologics USD 24.02M 5.75M Sep/2025
Dynavax Technologies USD 3.95M 1.25M Sep/2025
Eli Lilly USD 4.26B 186.5M Sep/2025
Halozyme Therapeutics USD 15.36M 3.33M Sep/2025
Insmed USD 79.59M 1.24M Sep/2025
MacroGenics USD 5.94M 1.28M Sep/2025
MannKind USD 7.27M 2.99M Sep/2025
Merck USD 4.15B 102M Sep/2025
Novo Nordisk DKK 4.46B 15.12B Jun/2025
Pfizer USD 5.02B 142M Sep/2025
Sanofi EUR 22.93B 927M Dec/2025
Xencor USD 9.08M 9.45M Sep/2025